[1]
P. Mancino, K. Falasca, C. Ucciferri, E. Pizzigallo, and J. Vecchiet, “USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS”, MJHID, vol. 2, no. 1, p. e2010003, Mar. 2010.